On one hand, IL-18 enhances the activity of cytotoxic T lymphocytes and natural killer (NK) cells, thereby boosting immune responses against tumor cells (Ohno et al., 2025; Shen et al., 2025). This evidence concerns the gene IL18 and neoplasm.